企業(yè)認(rèn)證
成都伊諾達(dá)博醫(yī)藥科技有限公司
小微企業(yè)
高新技術(shù)企業(yè)
科技型中小企業(yè)
瞪羚企業(yè)
We are offering three key services for new drug application,
a. Mature(repeatable) pilot process with independent intellectual property rights;
b. High purity sample designed for pharm companies;
c. Impurity study.
Our main products are Ulipristal acetate intermediates &impurities; Alogliptin benzoate intermediates, impurities &metabolin; Ezetimibe intermediates &impurities; Abiraterone Acetate; Dienogest; Tenofovir disoproxil fumarate & its intermediates; Bortezomib; Cabazitaxel; Lacosamide intermediates; Minodronic acid.
| 公司成立時(shí)間 |
2007/12/4 0:00:00 |
注冊(cè)資本 |
1500萬(wàn)元人民幣 |
| 經(jīng)營(yíng)范圍 |
研發(fā)、生產(chǎn)、銷售：醫(yī)藥中間體，化學(xué)藥品、生物藥品的技術(shù)開發(fā)及轉(zhuǎn)讓，化工產(chǎn)品的銷售，其它無(wú)需審批或許可的合法項(xiàng)目。
查看產(chǎn)品目錄 |
| 公司地址 |
1001, B6, No.88 Keyuan South Road, Chengdu Hi-Tech Zone, |
| 經(jīng)營(yíng)模式 |
工廠,工廠 |
主營(yíng)行業(yè) |
醫(yī)藥中間體,醫(yī)藥中間體,原料藥,原料藥 |
該企業(yè)工商信息校驗(yàn)數(shù)據(jù)由天眼查提供